BIOMAT Database Logo BIOMAT Database Logo

Reversible renal insufficiency and angiotensin-converting enzyme inhibitor therapy. 1992

J J Glazier, and J W Olin

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J J Glazier, and J W Olin
Reversible renal insufficiency and angiotensin-converting enzyme inhibitor therapy.
April 1992, Annals of internal medicine,
J J Glazier, and J W Olin
Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis.
October 1991, Annals of internal medicine,
J J Glazier, and J W Olin
Angiotensin-converting enzyme inhibitor therapy.
February 1992, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
J J Glazier, and J W Olin
Angiotensin converting enzyme inhibitor therapy.
January 1991, Therapia Hungarica (English edition),
J J Glazier, and J W Olin
Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
December 1985, Journal of clinical hypertension,
J J Glazier, and J W Olin
Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible.
December 1992, Journal of internal medicine,
J J Glazier, and J W Olin
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
April 1996, The New England journal of medicine,
J J Glazier, and J W Olin
Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy.
October 1990, The Quarterly journal of medicine,
J J Glazier, and J W Olin
Renal insufficiency due to angiotensin-converting enzyme inhibitors.
January 1994, Mineral and electrolyte metabolism,
J J Glazier, and J W Olin
Pharmacokinetics of temocapril hydrochloride, a novel angiotensin converting enzyme inhibitor, in renal insufficiency.
January 1992, European journal of clinical pharmacology,
Copied contents to your clipboard!